Testing a new drug for advanced solid tumors
Part of Cancer clinical trials.
This trial is testing an investigational drug called SIBP-A19 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have an advanced solid tumor that has not been helped by standard treatment or you cannot tolerate standard treatment.
- You are willing to provide a tumor sample (from a past biopsy or a new one) for testing.
- You have at least one tumor that can be measured on a scan.
- You are in fairly good health, able to care for yourself (ECOG score 0 or 1).
- If you are able to have children, you agree to use effective birth control during the trial and for 6 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SKB500 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and may help shrink tumors.
This early-phase trial tests an experimental drug called ICP-B794 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and begins to show signs of shrinking tumors.
This trial tests a new drug called SIBP-A10 for people with advanced cancer that has not responded to other treatments. It aims to see if the drug is safe and helps shrink tumors.
This trial tests a new drug, SIBP-A18, for people with advanced solid tumors that have not responded to standard treatments. It may be an option for those with certain cancers that have a protein called CLDN18.2.
This trial tests a new drug called SIBP-A13 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective for different cancer types, including lung, breast, and head and neck cancers.
This trial tests a new drug called SIBP-A17 for advanced solid tumors that have not responded to other treatments. It focuses on tumors that have a protein called HER2, and the goal is to see if the drug is safe and effective.
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.